WealthSource Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$557K Sell
6,872
-184
-3% -$14.3K 0.04% 299
2023
Q3
$529K Buy
7,056
+43
+0.6% +$3.31K 0.04% 296
2023
Q2
$541K Sell
7,013
-1,631
-19% -$130K 0.04% 300
2023
Q1
$717K Buy
8,644
+120
+1% +$9.94K 0.05% 238
2022
Q4
$732K Sell
8,524
-1,367
-14% -$108K 0.05% 237
2022
Q3
$610K Buy
9,891
+510
+5% +$32.2K 0.05% 264
2022
Q2
$580K Sell
9,381
-319
-3% -$19.8K 0.04% 280
2022
Q1
$577K Buy
9,700
+9
+0.1% +$575 0.04% 317
2021
Q4
$704K Buy
9,691
+1,322
+16% +$91.1K 0.06% 253
2021
Q3
$585K Sell
8,369
-939
-10% -$66K 0.05% 262
2021
Q2
$641K Buy
9,308
+5,109
+122% +$341K 0.06% 234
2021
Q1
$271K Sell
4,199
-2,416
-37% -$156K 0.03% 352
2020
Q4
$385K Buy
6,615
+418
+7% +$25.2K 0.04% 247
2020
Q3
$392K Buy
6,197
+677
+12% +$46.9K 0.05% 224
2020
Q2
$425K Sell
5,520
-1,203
-18% -$92.2K 0.06% 203
2020
Q1
$503K Sell
6,723
-944
-12% -$65.2K 0.08% 169
2019
Q4
$498K Sell
7,667
-6,109
-44% -$398K 0.07% 232
2019
Q3
$873K Sell
13,776
-503
-4% -$32.9K 0.13% 162
2019
Q2
$965K Buy
14,279
+8,976
+169% +$590K 0.15% 142
2019
Q1
$345K Buy
+5,303
New +$352K 0.08% 232
2018
Q3
Sell
-2,911
Closed -$206K 330
2018
Q2
$206K Buy
+2,911
New +$206K 0.06% 280
2017
Q1
Sell
-5,263
Closed -$377K 295
2016
Q4
$377K Sell
5,263
-562
-10% -$41.8K 0.16% 132
2016
Q3
$461K Sell
5,825
-298
-5% -$24.2K 0.17% 125
2016
Q2
$511K Buy
6,123
+885
+17% +$78.5K 0.19% 113
2016
Q1
$481K Buy
+5,238
New +$472K 0.2% 106

Other funds holding GILD

WealthSource Partners's GILD Position: Q4 2023 in Review

WealthSource Partners reduced its Gilead Sciences (GILD) stake by 2.6% in Q4 2023, selling an estimated $14.3K and leaving 6,872 shares worth $557K. The position accounts for 0.04% of the portfolio, ranked #299.

WealthSource Partners first reported a position in GILD in Q1 2016 and has held it in 25 quarters since. The position peaked at $965K in Q2 2019. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • WealthSource Partners held 6,872 shares of Gilead Sciences worth $557K as of Q4 2023.
  • WealthSource Partners sold 184 Gilead Sciences shares in Q4 2023, an estimated $14.3K.
  • Gilead Sciences made up 0.04% of WealthSource Partners's portfolio in Q4 2023, its #299 holding.
  • WealthSource Partners first reported a position in Gilead Sciences in Q1 2016 and has held it in 25 quarters since.
  • WealthSource Partners's Gilead Sciences position peaked at $965K in Q2 2019.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.